Global Cardiovascular Devices Market Overview 2023-2028

The global cardiovascular devices market size reached US$ 55.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 82.7 Billion by 2028, exhibiting a growth rate (CAGR) of 6.4% during 2023-2028.

Cardiovascular devices refer to a wide range of medical devices specifically designed to diagnose, treat, or manage conditions related to the heart and blood vessels. They are implanted within the body to address heart conditions. They play a critical role in modern healthcare, which helps medical professionals provide effective treatments and improve the quality of life for patients with cardiovascular diseases.

Global Cardiovascular Devices Market Trends and Drivers:

The growing cases of heart failure due to the surging prevalence of cardiovascular diseases (CVDs) represent one of the primary factors driving the demand for cardiovascular devices around the world. It can also be attributed to inactive lifestyles, unhealthy dietary patterns, high stress levels, diabetes, and obesity among the masses. Moreover, the increasing elderly population, which is more susceptible to medical conditions and significant improvements in the healthcare infrastructure, is favoring the growth of the market. In addition, the rising inclination towards minimally invasive surgeries (MIS) on account of their associated benefits is bolstering the market growth. Apart from this, the integration of advanced technologies, including artificial intelligence (AI), machine learning (ML), predictive analytics, sensors, and advanced algorithms for early detection of heart disease, treating strokes faster, and improving diagnostic radiology capabilities are contributing to the market growth. Besides this, increasing investment in research and development (RD) activities by key players are propelling the growth of the market.

Global Cardiovascular Devices Market 2023-2028 Analysis and Segmentation:

Top Key Players covered in this report are: Abbott Laboratories, B. Braun Melsungen AG, Biotronik, Boston Scientific Corporation, Canon Medical Systems Corporation, Cardinal Health Inc., Edwards Lifesciences Corporation, General Electric Company, LivaNova PLC, Medtronic PLC, Siemens Healthineers GmbH (Siemens AG) and Terumo Cardiovascular Systems Corporation (Terumo Corporation)

The report segmented the market on the basis of region, device type, application and end user.

Breakup by Device Type:

• Diagnostic and Monitoring Devices
• Electrocardiogram (ECG)
• Remote Cardiac Monitoring
• Others
• Therapeutic and Surgical Devices
• Cardiac Rhythm Management (CRM) Devices
• Catheter
• Stents
• Heart Valves
• Others

Breakup by Application:

• Coronary Artery Disease (CAD)
• Cardiac Arrhythmia
• Heart Failure
• Others

Breakup by End User:

• Hospitals
• Specialty Clinics
• Others

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

Key highlights of the report:

• Market Performance (2017-2022)
• Market Outlook (2023- 2028)
• Porter’s Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Services Private Limited.

134 N 4th St. Brooklyn, NY 11249, USA

Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800